INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi

Clinical trial NCT04945070 · UNKNOWN

Trial details

NCT number: NCT04945070
Sponsor: Institute for Clinical and Experimental Medicine
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Treated With Insulin

Start date: 2021-07-01
Primary completion: 2023-01-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.